Keogan D M, Twamley B, Fitzgerald-Hughes D, Griffith D M
Centre for Synthesis & Chemical Biology, Department of Pharmaceutical & Medicinal Chemistry, Royal College of Surgeons in Ireland, 123 St. Stephens Green, Dublin 2, Ireland.
School of Chemistry, Chemistry Building, Trinity College Dublin, Dublin 2, Ireland.
Dalton Trans. 2016 Jul 5;45(27):11008-14. doi: 10.1039/c5dt05061h.
Reaction of Bi(NO3)3 with benzohydroxamic acid (Bha) and salicylhydroxamic acid (Sha) gives the novel Bi(iii) complexes [Bi2(Bha-1H)2(μ-Bha-1H)2(η(2)-NO3)2] () and Bi6(CH3OH)2(η(1)-NO3)2(η(2)-NO3)(OH2)2(Sha-1H)122 (). X-ray crystal structure of reveals two hydroxamato coordination modes; bidentate bridging (O, O') and bidentate non-bridging (O, O') and of reveals one coordination mode; bidentate bridging (O, O'). , specifically designed to and demonstrated to inhibit the activity of urease, exhibits excellent antibacterial activity against three strains of Helicobacter pylori with MIC ≥ 16 μg mL(-1).
硝酸铋(Bi(NO3)3)与苯甲酰氧肟酸(Bha)和水杨酰氧肟酸(Sha)反应生成了新型的Bi(iii)配合物[Bi2(Bha-1H)2(μ-Bha-1H)2(η(2)-NO3)2]()和Bi6(CH3OH)2(η(1)-NO3)2(η(2)-NO3)(OH2)2(Sha-1H)122()。的X射线晶体结构显示出两种异羟肟酸配位模式;双齿桥连(O,O')和双齿非桥连(O,O'),而的则显示出一种配位模式;双齿桥连(O,O')。专门设计用于并证明可抑制脲酶活性,对三株幽门螺杆菌表现出优异的抗菌活性,MIC≥16μg mL(-1)。